QIC invests in Australian biotech start-upBY ELIZA BAVIN | MONDAY, 8 JUL 2024 12:00PMThe Queensland Investment Corporation said a $2.2 million pre-seed round will support the new investment. Related News |
Editor's Choice
Treasury considers reward system for whistleblowers
The government has opened consultation on a review of corporate whistleblowing laws in Australia to ensure they are working to effectively protect whistleblowers.
Raiz names new chief executive
The chief executive of Raiz Invest stepped down after nearly four years in the post and has been replaced by former Selfwealth chief Craig Keary.
What does a world with 'zero migration' look like?
Oxford Economics hypothesised an extreme scenario of "zero migration" globally and found while destination economies would see significant declines in output per capita, origin economies would have modest gains.
Invesco, Trinetra IM strategies to wind up
After failing to scale, Invesco's True Balance Fund and Trinetra Investment Management's emerging markets strategy are set to wind up.
Products
Expert Feed
When geopolitics becomes a portfolio risk
Geopolitics is back - again - and Australian investors can no longer treat it as distant background noise.
Does association membership still matter?
With all the changes the advice sector has experienced in recent years, such as regulatory reform and increased education and professional standards ...
Digital assets and where they stand in 2026
So far in 2026 digital assets have captured the headlines largely for the wrong reasons, but that doesn't tell the full story.
Rethinking default design in a changing market environment
The evolution underway in the US DC system highlights the value of periodically reassessing default design assumptions.
Featured Profile
David Woodall
CHIEF EXECUTIVE OFFICER, SUPERANNUATION
INSIGNIA FINANCIAL LTD
INSIGNIA FINANCIAL LTD
Facing his greatest test yet in metamorphosing MLC Super, Dave Woodall is adamant the juice will be worth the squeeze. Jamie Williamson writes.
